Chr. Hansen Highlights the Science Behind its Probiotics
Documented effect means that Probio-Tec products contain strains with an efficacy which is documented by human studies published in scientific journals.
15 Oct 2009 --- Chr. Hansen has re-launched its probiotic offerings for the dietary supplement, infant formula and pharmaceutical industries under a new tagline: “Probio-Tec... when science matters”.
“Over the past few months we have thoroughly analyzed the probiotic market place and our own position in it, “explains Chr. Hansen’s Charlotte Beyerholm, Marketing Manager, Health & Nutrition Division. “The purpose of the analysis was to scrutinize and improve the global promotion of our probiotics.”
According to Beyerholm, the conclusion was crystal-clear: The increasing focus on documentation and other key aspects of “science” among customers, authorities, consumers and other central stakeholders favors Chr. Hansen as the one probiotics supplier having a scientifically superior approach and product portfolio.
Probio-Tec criteria Chr. Hansen’s Probio-Tec products are characterized by four properties:
• Documented effect
• Documented stability
• Proven safety
• Multiple applications
Documented effect means that Probio-Tec products contain strains with an efficacy which is documented by human studies published in scientific journals. “This enables our customers to differentiate their consumer product on efficacy. Furthermore, the documented effect will increase consumer repurchases because the product has the intended effect – it works,” explains Lasse Nagell, Global Sales Director, Health & Nutrition Division.
Documented stability means that Chr. Hansen provides stability data from raw material to packed consumer product at relevant storage conditions. “Additionally, we ensure adequate cell count correlating to clinical documentation,” elaborates Nagell. “This secures that our customer’s product delivers on promise.”
Proven safety has three implications. Firstly, Probio-Tec products contain probiotic strains that have a documented history of origin, are well characterised, and with no adverse safety-related observations. Secondly, strain identity verification is part of Chr. Hansen’s quality control and, thirdly, the company secures full traceability from raw materials to final product. “The benefit for our customers is that there will be no unforeseen adverse effect from Probio-Tec strains,” Nagell points out.
Multiple applications means that Probio-Tec products are available in different dosage forms as well as customized solutions. Additionally, they are manufactured to meet specific industry requirements. “In other words,” explains Nagell, “we offer customers flexibility in customizing their product and our experience enables an effective product launch process.”
“From China through Italy to the US, Chr. Hansen probiotic customers all over the world will be familiar with the above key facts about their supplier’s premium probiotics. A wide range of communication and marketing activities will help us get the message across in the months to come,” concludes Beyerholm.
Chr. Hansen’s eight Probio-Tec strains for Gastrointestinal, Immune, Women's, and Infant Health are:
• Bifidobacterium BB-12
• Lactobacillus acidophilus LA-5
• Lactobacillus rhamnosus LGG
• Lactobacillus rhamnosus GR-1
• Lactobacillus reuteri RC-14
• Lactobacillus L. casei 431
• Lactobacillus F19
• Streptococcus thermophilus TH-4
